Penn Study Reveals Secrets of “Hot” and “Cold” Pancreatic Cancer Tumors
Perelman School of Medicine at the University of Pennsylvania“Hot” tumors filled with T cells are often considered to be more sensitive to immunotherapy compared to “cold” tumors with fewer T cells, but a clear demonstration of why has eluded cancer biologists—until now. Researchers discovered that whether a tumor is hot or cold is determined by information embedded in the cancer cells themselves, which could help oncologists more precisely tailor treatments to a patient’s unique tumor composition.